Data from FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Authors:
- Ashley WoodsAWAshley Woods
- Kelly J. NorsworthyKNKelly J. Norsworthy
- Xin WangXWXin Wang
- Jonathon VallejoJVJonathon Vallejo
- Edwin Chiu Yuen ChowECEdwin Chiu Yuen Chow
- Ruo-Jing LiRLRuo-Jing Li
- Jielin SunJSJielin Sun
- Rosane CharlabRCRosane Charlab
- Xiling JiangXJXiling Jiang
- Richard PazdurRPRichard Pazdur
- Marc R. TheoretMTMarc R. Theoret
- R. Angelo de ClaroRCR. Angelo de Claro
Open Access
- 1 April 2024
- other
- Published by American Association for Cancer Research (AACR)